Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Optinose revenue
Optinose's revenue is $78.2 million.
What is Optinose's revenue?
- Optinose's revenue growth from 2016 to 2024 is 64.69%.
- Optinose has 102 employees, and the revenue per employee ratio is $766,921.
- Optinose's peak quarterly revenue was $22.5M in 2021(q4).
- Optinose peak revenue was $78.2M in 2024.
- Optinose annual revenue for 2023 was 71.0M, -6.93% growth from 2022.
- Optinose annual revenue for 2024 was 78.2M, 10.2% growth from 2023.
On this page
Zippi applies for you, and finds you a job.
Optinose historical revenue
Optinose's peak revenue was $78.2M in 2024. The peak quarterly revenue was $22.5M in 2021(q4).
Optinose's revenue increased from $47.5m in 2016 to $78.2M currently. That's a 64.69% change in annual revenue.
Optinose annual revenue
Optinose annual revenue over time
| Fiscal year / year | Optinose revenue |
|---|---|
| 2016 | $47.5M |
| 2018 | $7.1M |
| 2019 | $34.6M |
| 2020 | $49.1M |
| 2021 | $74.7M |
| 2022 | $76.3M |
| 2023 | $71.0M |
| 2024 | $78.2M |
Rate Optinose's financial transparency
Optinose annual growth
Optinose saw the greatest revenue growth in 2019, when revenue increased by 390.18%.
Optinose had the lowest revenue growth in 2018, when revenue changed by -85.13%.
Optinose annual growth rate over time
| Year | Optinose growth |
|---|---|
| 2018 | -85%↓ |
| 2019 | 390%↑ |
| 2020 | 42%↑ |
| 2021 | 52%↑ |
| 2022 | 2%↑ |
| 2023 | -7%↓ |
| 2024 | 10%↑ |
Optinose quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Optinose quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | $865,000 | $1.3M | $1.9M | $3.0M |
| 2019 | $4.5M | $6.7M | $12.4M | $11.1M |
| 2020 | $7.1M | $10.3M | $15.4M | $16.3M |
| 2021 | $12.0M | $18.4M | $21.8M | $22.5M |
| 2022 | $14.8M | $20.6M | $20.1M | $20.9M |
| 2023 | $11.8M | $19.5M | $19.8M | $19.9M |
| 2024 | $14.9M | $20.5M | $20.4M | $22.4M |
Optinose jobs nearby
Do you work at Optinose?
Is Optinose transparent about its revenue structure?
Optinose financing
Optinose received early financing of $48.8M on 2010-06-21.
| Series | Round size | Date |
|---|---|---|
| Equity | $5.4M | 09/2019 |
| Equity | $35M | 04/2017 |
| Equity | $35.0M | 10/2015 |
| Equity | $48.8M | 06/2010 |
Optinose investors
| Investors | Security type |
|---|---|
| Athyrium Capital Management, LP | Post-IPO Debt - OptiNose |
| Avista Capital Partners | Series D - OptiNose |
| Fidelity Management and Research Company | Series D - OptiNose |
| Entrepreneurs Fund | Series D - OptiNose |
| Avista Capital Partners | Series C - OptiNose |
| The Entrepreneurs' Fund | Series C - OptiNose |
| WFD Ventures | Series C - OptiNose |
| Avista Capital Partners | Series C - OptiNose |
| Entrepreneurs Fund | Series C - OptiNose |
| WFD Ventures | Series C - OptiNose |
Search for jobs
Optinose highest paying jobs
Zippia gives an in-depth look into the details of Optinose, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Optinose. The employee data is based on information from people who have self-reported their past or current employments at Optinose. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Optinose. The data presented on this page does not represent the view of Optinose and its employees or that of Zippia.
Optinose may also be known as or be related to OPTINOSE, INC., OptiNose, OptiNose US Inc, OptiNose, Inc., Optinose and Optinose, Inc.